Patent details
300771
Product Name:
Combinatie van HPV L1 VLPs 16, 18 en 31
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300771
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1758609
Status:
SPC in force
Application number:
300771
Procedural language:
Dutch
First Applicant Residence Country:
Belgium (BE)
Paediatric Extension
SPC Extension Filing Date:
02/11/2022
SPC Extension Agent/Owner Name:
dr. R.C. van Duijvenbode c.s.
, GlaxoSmithKline Biologicals SA
SPC Extension Status:
Extension Granted
SPC Extension Grant Date:
14/12/2022
SPC Extension Request Refusal Date:
SPC Extension Revocation Date:
Marketing Authorization
Marketing Authorization Number:
EU/1/15/1007/001-003
Marketing Authorization Type:
EEA
Marketing Authorization Date:
12/06/2015
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
30/11/2015
First Marketing Authorization date:
12/06/2015
Grant date:
29/12/2015
Activation date:
14/06/2025
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
11/12/2015
SPC/SPC Extension Expiration Date:
11/12/2030
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
30/11/2015
Name:
GlaxoSmithKline Biologicals SA
Address:
Rue de l'Institut 89, 1330 RIXENSART, Belgium (BE)
Agent
1
Name:
dr. R.C. van Duijvenbode c.s.
From:
02/11/2022
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
2
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
11/12/2015
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
02/11/2022
Publication
Bulletin
1
Bulletin Heading:
SPC
Journal edition number:
25/25
Publication date:
18/06/2025
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
Bulletin Heading:
SPC
Journal edition number:
51/22
Publication date:
21/12/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
SPC
Journal edition number:
46/22
Publication date:
16/11/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
Bulletin Heading:
SPC
Journal edition number:
53/15
Publication date:
30/12/2015
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
5
Bulletin Heading:
SPC
Journal edition number:
51/15
Publication date:
16/12/2015
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
30/06/2027
Annual Fee Number:
23
Annual Fee Amount:
2000 Euro
Last Annual Payment Date:
23/03/2026
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
1800 Euro
Payer:
Master Data Center
Filing date
Document type
Document Description
Number of pages
File Type
14/12/2022
Outgoing Correspondence
Decision extension duration
1
PDF
/8/7/3/9/1/0800019378/docs/300771_8_520127l504c.pdf
14/12/2022
Certificate
Certificate
1
PDF
/8/7/3/9/1/0800019378/docs/300771_9_spcxcertificate20221214121536847.pdf
17/11/2022
Outgoing Correspondence
Confirmation receipt request for extension
1
PDF
/8/7/3/9/1/0800019378/docs/300771_15_515422l505.pdf
02/11/2022
SPC Documents
Annex SPC
1
PDF
/8/7/3/9/1/0800019378/docs/300771_7_supplprotectioncertificate20221102033338998.pdf
02/11/2022
Application Form
First filed application form
2
PDF
/8/7/3/9/1/0800019378/docs/300771_10_applicationform20221102032024930.pdf
02/11/2022
SPC Documents
Summary of the characteristics of the product
37
PDF
/8/7/3/9/1/0800019378/docs/300771_11_supplprotectioncertificate20221102032156525.pdf
02/11/2022
SPC Documents
Annex SPC
2
PDF
/8/7/3/9/1/0800019378/docs/300771_12_supplprotectioncertificate20221102032234170.pdf
02/11/2022
SPC Documents
Marketing Authorization SPC
4
PDF
/8/7/3/9/1/0800019378/docs/300771_13_supplprotectioncertificate20221102032316177.pdf
02/11/2022
SPC Documents
Annex SPC
1
PDF
/8/7/3/9/1/0800019378/docs/300771_14_supplprotectioncertificate20221102032351869.pdf
29/12/2015
SPC Documents
Certificate SPC
1
PDF
/8/7/3/9/1/0800019378/docs/300771_3_supplprotectioncertificate20201209045150208.pdf
29/12/2015
Outgoing Correspondence
Outgoing Letter
2
PDF
/8/7/3/9/1/0800019378/docs/300771_4_outgoingcorrespondence20201209045305409.pdf
11/12/2015
Outgoing Correspondence
Outgoing Letter
1
PDF
/8/7/3/9/1/0800019378/docs/300771_2_outgoingcorrespondence20201209044847910.pdf
30/11/2015
SPC Documents
Annex SPC
1
PDF
/8/7/3/9/1/0800019378/docs/300771_0_supplprotectioncertificate20201209044143406.pdf
30/11/2015
Application Form
First filed application form
2
PDF
/8/7/3/9/1/0800019378/docs/300771_1_applicationform20151210015319069.pdf
30/11/2015
SPC Documents
Marketing Authorization SPC
4
PDF
/8/7/3/9/1/0800019378/docs/300771_5_supplprotectioncertificate20201209044027887.pdf
30/11/2015
SPC Documents
Summary of the characteristics of the product
37
PDF
/8/7/3/9/1/0800019378/docs/300771_6_supplprotectioncertificate20201209043424226.pdf